Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 21, 2024 09:24 ET | Source: Purdue Research Foundation

Eradivir’s EV25 therapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies

WEST LAFAYETTE, Ind., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Eradivir, a preclinical biotech company that licenses innovations from Purdue Research Foundation, has developed a patent-pending antiviral...
August 30, 2024 05:38 ET | Source: Research and Markets

Preclinical Imaging (In-VIVO) Strategic Research Report 2023-2030: Adoption of AI and Machine Learning in Image Analysis Drives Market Dynamics

Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Preclinical Imaging (In-VIVO) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
July 09, 2024 14:24 ET | Source: Purdue Research Foundation

Biotech company Eradivir is developing lead drug EV25 to treat influenza

WEST LAFAYETTE, Ind., July 09, 2024 (GLOBE NEWSWIRE) -- Eradivir, a preclinical biotech company, leverages small molecule targeting technology developed in Philip Low’s lab at Purdue University to...
June 07, 2024 03:32 ET | Source: Research and Markets

GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials

Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Global GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. In...
May 14, 2024 05:38 ET | Source: Research and Markets

Global PIM Kinase Targeted Therapies Market Opportunity & Clinical Trials Report 2024: USA Dominating with 5 Therapies, FDA Orphan Designation, Proprietary Development Technologies by Companies

Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Global PIM Kinase Targeted Therapies Market Opportunity & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering....
April 29, 2024 07:32 ET | Source: Research and Markets

Global CD70 Targeting Therapies Market & Clinical Trials Report 2024 - Insight by Company, Country, Indication & Phase

Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...
April 15, 2024 09:47 ET | Source: Research and Markets

Global In Vivo CRO Market Analysis Report 2024-2030, Featuring IQVIA, Crown Bioscience, Taconic Biosciences, PsychoGenics, Evotec, Janvier Labs, Biocytogen Boston, GemPharmatech and Parexel

Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Global In Vivo CRO Market Size, Share & Trends Analysis Report by Model Type (Rodent Based, Non-rodent Based), Modality (Small Molecule, Large...
March 21, 2024 12:44 ET | Source: Research and Markets

Global Mice Model Market Set to Surpass USD 2.2 Billion by 2029, Driven by Enhanced Drug Discovery and Genetic Research

Dublin, March 21, 2024 (GLOBE NEWSWIRE) -- The "Global Mice Model Market by Model Types (Inbred, Outbred, Hybrid), Services (Breeding, Rederivation), Technology (Microinjection, CRISPR/Cas9),...
January 29, 2024 13:09 ET | Source: Research and Markets

TC-210 Drug and Market Report 2023-2032: Revolutionizing the Malignant Pleural Mesothelioma (MPM) Treatment Landscape

Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "TC-210 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The clinical landscape of...
January 29, 2024 11:34 ET | Source: Research and Markets

U.S. Cell and Gene Therapy Clinical Trial Services Market 2024-2030: A $28.58 Billion Opportunity

Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "U.S. Cell and Gene Therapy Clinical Trial Services Market Size, Share & Trends Analysis, 2024-2030" report has been added to ...